ENDRA Life Sciences Inc.
NDRA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,596 | -$1,226 | -$1,036 | -$4,149 |
| Dep. & Amort. | $39 | $33 | $46 | $46 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $145 | $89 | $83 | $105 |
| Change in WC | -$19 | $53 | $23 | $211 |
| Other Non-Cash | $267 | -$62 | -$409 | $2,271 |
| Operating Cash Flow | -$1,164 | -$1,114 | -$1,293 | -$1,516 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$17 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | -$17 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $149 | $857 | $146 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $149 | $857 | $146 | $0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$1,015 | -$256 | -$1,165 | -$1,516 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,809 | $2,065 | $3,229 | $4,745 |
| End Cash | $794 | $1,809 | $2,065 | $3,229 |
| Free Cash Flow | -$1,164 | -$1,114 | -$1,310 | -$1,516 |